Home | Welcome to Contract Pharma   
Last Updated Friday, August 29 2014
Print

Trials & Filings in Brief: Oct. 31, 2013



By Gil Roth



Published October 31, 2013
Related Searches: formulation www.contractpharma.com Phase II contractpharma
Phase I
Kamada reports preliminary pediatric diabetes data . . . read more

Phase II
e-Therapeutics starts trial of tramadol CR formulation . . . read more

Phase III
Teva gets approval for CHF trial . . . read more

Post-Approval
Hyperion begins UCD outcomes study . . . read more

Filings
Ariad suspends Iclusig marketing in U.S. . . . read more

Baxter submits Rixubis in EU . . . read more

Stem Cell Therapeutics gets Orphan status for tigecycline in AML . . . read more


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On